| ²é¿´: 663 | »Ø¸´: 2 | ||
| ±¾Ìû²úÉú 1 ¸ö ·ÒëEPI £¬µã»÷ÕâÀï½øÐв鿴 | ||
wqssfj1Ìú¸Ëľ³æ (ÖøÃûдÊÖ)
|
[ÇóÖú]
ÇóÖú·Ò룡£¡£¡
|
|
|
They are less common with the low systemic exposure associated with inhaled devices compared to the higher doses given with systemic formulations. ¸Ã¾äÉÏÎÄΪ£º×Ô20ÊÀ¼Í60Äê´úÖÐÆÚ£¬É³¶¡°·´¼ÒÑÓÃÓÚÁÙ´²£¬ÍêȫȷÁ¢Á˰²È«ÐÔÌØÕ÷¡£È«ÇòÊý°ÙÍò»¼ÕßÒѳɹ¦Ê¹ÓøÃÒ©Îï40ÓàÄê¡£Æä¸±×÷ÓÃΪ¼ÁÁ¿ÒÀÀµÐÔ£¬ÓÉÓÚ¦Â2-¼¤¶¯¼ÁµÄҩЧѧ»úÖÆ£¬×î³£¼ûµÄ¸±×÷ÓÃΪÇá¶ÈÕð²ü¡¢Í·Í´ºÍÐ͝¹ýËÙ¡£·¢ÏÖ¸ÃÀà±ðµÄÈ«²¿Ò©Îï¾ùÓÐÉÏÊö±íÏÖ¡£ ÏÂÎÄΪ£º¿ÉÄÜ»á³öÏÖì¶ÜÐÔÖ§Æø¹Ü¾·ÂΣ¬Èô¸Ãʼþ³öÏÖ£¬Ó¦Á¢¼´Í£ÓÃɳ¶¡°·´¼²¢²ÉÓÃÌæ´úÁÆ·¨¡£ ¶àл£¡ |
» ²ÂÄãϲ»¶
353Çóµ÷¼Á
ÒѾÓÐ7È˻ظ´
Çóµ÷¼Á
ÒѾÓÐ7È˻ظ´
²ÄÁÏ»¯¹¤306·ÖÕÒºÏÊʵ÷¼Á
ÒѾÓÐ11È˻ظ´
µ÷¼Á
ÒѾÓÐ8È˻ظ´
¹¤¿ÆÇóµ÷¼Á
ÒѾÓÐ13È˻ظ´
¸´ÊÔµ÷¼Á
ÒѾÓÐ5È˻ظ´
Ò»Ö¾Ô¸±±¾©»¯¹¤085600 310·ÖÇóµ÷¼Á
ÒѾÓÐ11È˻ظ´
Ò»Ö¾Ô¸±±¾©2£¬²ÄÁÏÓ뻯¹¤308Çóµ÷¼Á
ÒѾÓÐ10È˻ظ´
0817»¯Ñ§¹¤³ÌÓë¼¼ÊõÇóµ÷¼Á£¬Ò»Ö¾Ô¸Öк£Ñó319
ÒѾÓÐ9È˻ظ´
Ò»Ö¾Ô¸µç×ӿƼ¼´óѧ085600²ÄÁÏÓ뻯¹¤ 329·ÖÇóµ÷¼Á
ÒѾÓÐ6È˻ظ´
zhoumin235
Òø³æ (СÓÐÃûÆø)
- ·ÒëEPI: 17
- Ó¦Öú: 47 (СѧÉú)
- ½ð±Ò: 138
- É¢½ð: 362
- ºì»¨: 4
- Ìû×Ó: 285
- ÔÚÏß: 212.5Сʱ
- ³æºÅ: 668891
- ×¢²á: 2008-12-05
- ÐÔ±ð: GG
- רҵ: É«Æ×·ÖÎö

2Â¥2012-07-05 14:32:34
·çÖ®»êÁézd
ľ³æ (ÕýʽдÊÖ)
- ·ÒëEPI: 27
- Ó¦Öú: 6 (Ó×¶ùÔ°)
- ½ð±Ò: 3067.7
- É¢½ð: 136
- ºì»¨: 5
- Ìû×Ó: 859
- ÔÚÏß: 163.1Сʱ
- ³æºÅ: 1408157
- ×¢²á: 2011-09-19
- ÐÔ±ð: GG
- רҵ: º£ÑóÒ©Îï

3Â¥2012-07-06 16:00:13














»Ø¸´´ËÂ¥